Status:

RECRUITING

Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke

Lead Sponsor:

Centre Hospitalier de Gonesse

Conditions:

Stroke, Ischemic

Thrombectomy

Eligibility:

All Genders

18+ years

Brief Summary

This study, called TARGET-ASPECT, looks at patients who had a type of stroke called acute ischemic stroke and were treated with clot-busting medicine and a procedure to remove the clot. Even with thes...

Eligibility Criteria

Inclusion Criteria :

  • Patients aged 18 years or older
  • Confirmed acute ischemic stroke on imaging
  • Treated with both thrombolysis and thrombectomy
  • Clinical follow-up data available at 90 days (mRS score)

Exclusion Criteria :

  • Primary hemorrhagic stroke
  • Early death or loss to follow-up without evaluation
  • Poor-quality imaging that cannot be analyzed

Key Trial Info

Start Date :

April 15 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 15 2026

Estimated Enrollment :

152 Patients enrolled

Trial Details

Trial ID

NCT07069452

Start Date

April 15 2025

End Date

January 15 2026

Last Update

July 16 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centre Hospitalier de Gonesse

Gonesse, France

Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke | DecenTrialz